International Journal of Cancer Management

Published by: Kowsar

Clinical Outcome and Prognostic Factors for Nasopharyngeal Carcinoma: A Single Institution Study in Iran

Ahmad Ameri 1 , Nafiseh Mortazavi 2 , Amir Shahram Yousefi Kashi 1 and Kambiz Novin 1 , *
Authors Information
1 Department of Radiation Oncology, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Pathology, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of Cancer Management: March 2017, 10 (3); e5846
  • Published Online: March 25, 2017
  • Article Type: Research Article
  • Received: March 2, 2016
  • Revised: March 17, 2016
  • Accepted: March 1, 2017
  • DOI: 10.5812/ijcm.5846

To Cite: Ameri A, Mortazavi N, Yousefi Kashi A S, Novin K. Clinical Outcome and Prognostic Factors for Nasopharyngeal Carcinoma: A Single Institution Study in Iran, Int J Cancer Manag. 2017 ; 10(3):e5846. doi: 10.5812/ijcm.5846.

Abstract
Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Petersson F. Nasopharyngeal carcinoma: a review. Seminars in diagnostic pathology. 2015;
  • 2. Wided BA, Hamouda B, Hamadi H, Mansour BA. Nasopharyngeal carcinoma incidence in North Tunisia: negative trends in adults but not adolescents, 1994-2006. Asian Pac J Cancer Prev. 2015; 16(7): 2653-7[PubMed]
  • 3. Safavi A, Raad N, Raad N, Ghorbani J. Epidemiology of Nasopharyngeal Cancers in Iran: A 6-year Report. Asian Pac J Cancer Prev. 2015; 16(10): 4447-50[PubMed]
  • 4. Wang R, Tan Y, Wang X, Ma L, Wang D, Hu Y, et al. Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of China. PloS one. 2014; 9(11)
  • 5. Chan JKC, Pilch BZ, Bray F. WHO Classification of Tumours. 2005; : 85-97
  • 6. Kalaghchi B, Kazemian A, Hashem FA, Aghili M, Farhan F, Haddad P. Chemoradiation in nasopharyngeal carcinoma: a 6-year experience in Tehran cancer institute. Acta Med Iran. 2011; 49(1): 49-53[PubMed]
  • 7. Kim S, Smith BD, Haffty BG. Head and Neck Cancer: A Multidisciplinary Approach. 2013; : 87-111
  • 8. Lok BH, Setton J, Ho F. Perez and Brady's Principles and Practice of Radiation Oncology. 2013; : 730-60
  • 9. Ng WT, Chang AT, Lee SW, Sze HC, Lee AW. Chemotherapy for Nasopharyngeal Cancer: Neoadjuvant, Concomitant, and/or Adjuvant. Curr Treat Options Oncol. 2015; 16(9): 44[DOI][PubMed]
  • 10. Liu MT, Hsieh CY, Chang TH, Lin JP, Huang CC, Wang AY. Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol. 2003; 33(10): 501-8[PubMed]
  • 11. Mak HW, Lee SH, Chee J, Tham I, Goh BC, Chao SS, et al. Clinical outcome among nasopharyngeal cancer patients in a multi-ethnic society in Singapore. PloS one. 2015; 10(5)
  • 12. Novin K, Ameri A, Faraji S, Torbati P, Mortazavi N. Head and Neck Squamous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival. Iran J Cancer Prev. 2015; 8(5)[DOI][PubMed]
  • 13. Fountzilas G, Ciuleanu E, Bobos M, Kalogera-Fountzila A, Eleftheraki AG, Karayannopoulou G, et al. Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation. Ann Oncol. 2012; 23(2): 427-35[DOI][PubMed]
  • 14. Xu L, Pan J, Wu J, Pan C, Zhang Y, Lin S, et al. Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break. Radiother Oncol. 2010; 96(1): 94-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments